No Data
Rating information (Target Price change - part 2) = SUMCO, Chugai Pharmaceutical, ETC.
◎ Mizuho Securities (three levels: Buy > Hold > underperform) SUMCO <3436.T> -- "Buy" → "Buy", 2300 yen → 2100 yen UBE <4208.T> -- "Buy" → "Buy", 3600 yen → 3000 yen M3 <2413.T> -- "Hold" → "Hold", 1600 yen → 1900 yen ◎ Morgan Stanley MUFG Securities (three levels: Overweight > Equal Weight > Underweight) Chugai Pharmaceutical <4519.T> -- "Overweight"
Growth 250 has fallen for four consecutive days, with companies like Timee being sold off = Emerging Markets, 25th.
The TSE Growth Index fell for the fourth consecutive day. While the overall Tokyo market exhibited a sluggish trend, the growth market also faced selling pressure from Timee <215A.T>, Trial Holdings <141A.T>, and BASE <4477.T>. On the other hand, Cover <5253.T> and Plaid <4165.T> saw gains. Recently listed IPOs Booking Resort <324A.T> and Technology Succession Organization <319A.T> both reached the daily limit up. Provided by Wealth Advisor.
With the decrease in trading volume, the rise has paused, and attention is focused on whether the major stocks with large Market Cap can bounce back.
■Caution against risk-averse selling This week, Emerging Markets are likely to perform relatively well compared to Large Cap stocks, which are more susceptible to currency fluctuations, but the upside may be capped. The Growth Market 250 Index has reached 693.92 points on the 13th and is now experiencing a slight adjustment phase. Trading volume has decreased after peaking at 218.5 billion yen on the 17th, indicating a pause in the recent short-term uptrend. While the atmosphere of a sudden crash is not particularly strong, similar to Large Cap stocks, the European Index.
Trial, BASE [Emerging Markets Rating List]
"Mizuho" <141A> Trial Buy Hold "Daiwa" <4477> BASE 2→3 Downgrade * The ratings of the above companies are as per our records as of 02/19.
Japan paper, NRI, ETC (additional) Rating
Upgraded - Bullish Code Stock Name Brokerage Firm Previous Change After --------------------------------------------------------- <3861> Oji Holdings Nomura "Neutral" "Buy" Downgraded - Bearish Code Stock Name Brokerage Firm Previous Change After --------------------------------------------------------- <4477> BASE Daiwa "2" "3"
Rating information (Target Price change - Part 2) = Trial, Skylark, ETC.
◎ Mizuho Securities (three-tier evaluation: Buy > Hold > Underperform) Trial <141A.T> — "Buy" → "Buy", 4,200 yen → 3,400 yen Matsukiyo <3088.T> — "Buy" → "Buy", 3,200 yen → 3,400 yen Nitori HD <9843.T> — "Buy" → "Buy", 21,000 yen → 20,000 yen Sando Drug <9989.T> — "Buy" → "Buy", 6,100 yen → 6,000 yen ◎ Morgan Stanley MUFG Securities (three-tier evaluation: Overperform